SCHEMBL19980683

SCHEMBL19980683

O=Cc1cc(F)ccc1-n1cc(C2CCN(Cc3ccc4oc(=O)[nH]c4c3)C2)c2ccncc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.44
MCHR2 Q969V1 3/20 0.44
MCHR1 Q99705 3/20 0.44
CCNT1 O60563 2/20 0.34
CDK9 P50750 2/20 0.34
ATXN2 Q99700 1/20 0.34
GRIN2D O15399 2/20 0.33
GRIN3B O60391 2/20 0.33
GRIN1 Q05586 2/20 0.33
GRIN2A Q12879 2/20 0.33
GRIN2B Q13224 2/20 0.33
GRIN2C Q14957 2/20 0.33
GRIN3A Q8TCU5 2/20 0.33
HTR1A P08908 2/20 0.33
ACHE P22303 1/20 0.33
HTR1B P28222 1/20 0.33
DRD2 P14416 1/20 0.33
ROCK2 O75116 1/20 0.32
CCR2 P41597 1/20 0.32
ROCK1 Q13464 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19972543 0.86 MCHR1 (0.44) KCNH2MCHR2MCHR1CCNT1CDK9
SCHEMBL21141133 0.85 KCNH2 (0.43) KCNH2MCHR2MCHR1CCNT1CDK9
SCHEMBL25135199 0.80 HRH2 (0.43) KCNH2CCNT1CDK9ACHEROCK2
SCHEMBL25135195 0.76 HRH2 (0.40) HTR1AHTR1BDRD2CCR2HRH2
SCHEMBL26005871 0.75 OPRL1 (0.38)
SCHEMBL26005882 0.75 IDO1 (0.33) ROCK2
SCHEMBL26004878 0.74 DRD2 (0.37) KCNH2HTR1AHTR1BDRD2HRH2
SCHEMBL25135242 0.74 KCNH2 (0.42) KCNH2CDK9HTR1AHTR1BDRD2
SCHEMBL26006720 0.74 DRD2 (0.36) HTR1AHTR1BDRD2
SCHEMBL19972638 0.73 CDK9 (0.34) CCNT1CDK9ACHEDRD2HRH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4230627-A2 INHIBITORS OF THE MENIN-MLL INTERACTION Vitae Pharmaceuticals, LLC (US) 2023-08-23 EP disclosed
WO-2018053267-A1 INHIBITORS OF THE MENIN-MLL INTERACTION VITAE PHARMACEUTICALS, INC. (US) 2018-03-22 WO disclosed